Robert Whitehead, former president and general manager ofSearle Canada and senior vice president of SolvayPharmaceuticals, has been named president, chief executiveofficer and a director of Houghten Pharmaceuticals Inc. Hesucceeds Richard Houghten as CEO. Houghten, a founder of theprivate San Diego company, will become chief scientific officer.
London-based Cortecs International Ltd. has appointed RightHonorable The Lord Colwyn as a non-executive director.Colwyn presently sits on several All-Party Parliamentarygroups, including those on drug misuse, food and health, mediaand AIDS.
Edward McCracken, president and chief executive officer ofSilicon Graphics Inc., has joined the board of directors ofTularik Inc. of South San Francisco, Calif.
Alkermes Inc. has hired Donna LaVoie as director of corporatecommunications. She joined the Cambridge, Mass., companyfrom Genzyme Corp., where she was manager of publicrelations.
Robert Finder, former director of manufacturing at Rhone-Poulenc Inc., has joined Ecogen Inc. of Langhorne, Pa., as vicepresident of manufacturing.
Osteotech Inc. of Shrewsbury, N.J., has appointed Wendy Dixonexecutive vice president and general manager of internationaloperations. Dixon had been vice president of worldwidebusiness development for Centocor Inc.
DynaGen Inc. of Cambridge, Mass., has added Mark Skaletsky toits board of directors. Skaletsky is the president and chiefexecutive officer of GelTex Pharmaceuticals Inc.
American Biogenetic Sciences Inc. of Notre Dame, Ind., hasnamed John Proctor to its scientific advisory board. He issecretary general of the World Academy of Art and Science andpresident of the Washington (D.C.) Academy of Sciences.
(c) 1997 American Health Consultants. All rights reserved.